{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:44:59Z","timestamp":1791402299969,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1532\/ijh97.06079","type":"journal-article","created":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T11:46:39Z","timestamp":1172490399000},"page":"121-127","source":"Crossref","is-referenced-by-count":16,"title":["The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Japanese Multicenter Randomized, Controlled Study"],"prefix":"10.1007","volume":"85","author":[{"given":"Yoshikazu","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Mugitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Masaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Bow EJ, Laverdi\u00e8re M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients. <i>Cancer.<\/i> 2002;94:3230-3246."},{"key":"E00002","unstructured":"Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. British Society for Antimicrobial Chemotherapy Working Party. <i>Cancer.<\/i> 2000;89:1611-1625."},{"key":"E00003","unstructured":"Shivji A, Noble MA, Bernstein M. Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party. <i>Lancet.<\/i> 1991;337:1577-1580."},{"key":"E00004","unstructured":"Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. <i>J Antimicrob Chemother.<\/i> 1998;42:741-745."},{"key":"E00005","unstructured":"Glasmacher A, Prentice A, Gorschl\u00fcter M, et al. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. <i>J Clin Oncol.<\/i> 2003;21:4615-4626."},{"key":"E00006","unstructured":"Vardakas KZ, Michalopoulos A, Falagas ME. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. <i>Br J Haematol.<\/i> 2005;131:22-28."},{"key":"E00007","unstructured":"Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, de Beule K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. <i>Mycoses.<\/i> 1989;32:103-108."},{"key":"E00008","unstructured":"Toubai T, Tanaka J, Fujisawa F, Kondo Y, Imamura M. Effect of prophylaxis against mycosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole [in Japanese]. <i>Jpn J Antibiot.<\/i> 2003;56:61-65."},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Tamura K, Imajo K, Akiyama N, et al. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. <i>Clin Infect Dis.<\/i> 2004;39:S15-S24.","DOI":"10.1086\/383046"},{"key":"E00010","unstructured":"Yoshida M, Akiyama N, Takahashi M, et al. Management of infectious complications in patients with acute leukemia during chemotherapy: a questionnaire analysis by the Japan Adult Leukemia Study Group [in Japanese]. <i>Jpn J Chemother.<\/i> 2003;51:703-710."},{"key":"E00011","unstructured":"Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infection in patients under going bone marrow transplantation. <i>N Engl J Med.<\/i> 1992;326:845-851."},{"key":"E00012","unstructured":"Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective randomized doubleblind study. <i>J Infect Dis.<\/i> 1995;171:1545-1552."},{"key":"E00013","unstructured":"Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. <i>Clin Infect Dis.<\/i> 2002;34:7-14."},{"key":"E00014","unstructured":"Deep-seated Mycosis Guidelines Editorial Committee. <i>Guidelines for the Diagnosis and the Treatment of Deep-Seated Mycosis<\/i> [in Japanese]. Tokyo, Japan: Ishiyaku Publishers; 2003."},{"key":"E00015","unstructured":"Klastersky J. Febrile neutropenia. <i>Curr Opin Oncol.<\/i> 1993;5:625-632."},{"key":"E00016","unstructured":"Klastersky J. Anti-fungal therapy in patients with fever and neutropenia: more rational and less empirical? <i>N Engl J Med.<\/i> 2004;351:1445-1447."},{"key":"E00017","unstructured":"Annaloro C, Oriana A, Tagliaferri E, et al. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation. <i>Haematologica.<\/i> 1995;80:512-517."},{"key":"E00018","unstructured":"Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW, on behalf of the U.K. Multicentre Antifungal Prophylaxis Study Group. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. <i>Br J Haematol.<\/i> 1999;105:901-911."},{"key":"E00019","unstructured":"H\u00fcijgens PG, Simoons-Smit AM, van Loenen AC, et al. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. <i>J Clin Pathol.<\/i> 1999;52:376-380."},{"key":"E00020","unstructured":"Winston DJ, Maziarz RT, Chandrasekar PH, et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term anti-fungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. <i>Ann Intern Med.<\/i> 2003;138:705-713."},{"key":"E00021","unstructured":"Marr KA, Crippa F, Leisenring W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. <i>Blood.<\/i> 2004;103:1527-1533."},{"key":"E00022","unstructured":"Falagas ME, Vardakas KZ, Michalopoulos A. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancies: response to Prentice et al. <i>Br J Haematol.<\/i> 2006;132:658-659."},{"key":"E00023","unstructured":"Prentice AG, Glasmacher A, Djulbegvic B. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancies. <i>Br J Haematol.<\/i> 2006;132:656-658."},{"key":"E00024","unstructured":"Yamaguchi N, Ito Y, Ohyashiki K. Increased intracellular activity of matrix metalloproteinases in neutrophils may be associated with delayed healing of infection without neutropenia in myelodysplastic syndromes. <i>Ann Hematol.<\/i> 2005;84:383-388."},{"key":"E00025","unstructured":"M\u00fchlemann K, Wenger C, Zenh\u00e4esern R, T\u00e4uber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. <i>Leukemia.<\/i> 2005;19:545-550."},{"key":"E00026","unstructured":"Maschmeyer G, Ruhnke M. Update on antifungal treatment of invasive <i>Candida<\/i> and <i>Aspergillus<\/i> infections. <i>Mycoses.<\/i> 2003;47:263-276."},{"key":"E00027","unstructured":"Kamaluddin M, McNally P, Breatnach F, et al. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. <i>Acta Paediatr.<\/i> 2001;90:1204-1207."},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Kageyama S, Masuya M, Tanaka I, et al. Plasma concentration of itraconazole and prophylactic efficacy in patients with neutropenia after chemotherapy for acute leukemia. <i>J Infect Chemother<\/i> 1999;5:213-216.","DOI":"10.1007\/s101560050038"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Prentice AG, Glasmacher A. Making sense of itraconazole pharmacokinetics. <i>J Antimicrob Chemother.<\/i> 2005;56(suppl 1):i17-i22.","DOI":"10.1093\/jac\/dki220"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T19:11:43Z","timestamp":1556133103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["LJ62Q7L171H93434"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06079","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,1]]}}}